Full Breakdown
DRC Ebola Outbreak: Fastest-Growing Surge Traced to February, Declared in Mid-May
8/11/2026, 12:52:26 AM
Core Event – Outbreak Timeline and Scale
Sequencing data reviewed by the World Health Organization (WHO) indicate that the current Ebola outbreak in the Democratic Republic of Congo (DRC) began in February 2026, months before the official declaration on May 15. The outbreak is caused by the rare Bundibugyo strain, for which no licensed vaccine or treatment exists. As of the latest government report, confirmed cases total 4,200, with at least 1,900 deaths.
Background – Late Declarations and the Bundibugyo Strain
The Bundibugyo virus differs from the more common Zaire strain that the licensed Ervebo vaccine targets. Past Ebola emergencies, including the 2014-2016 West Africa epidemic, were also declared weeks or months after the first cases emerged. That West African outbreak was declared in March 2014, although the earliest human case was later identified in December 2013.
Data & Statistics
- Confirmed cases: 4,200 (government figures)
- Deaths: >= 1,900 (government figures)
- New cases are doubling in several hotspots, according to WHO surveillance.
- Health authorities estimate that 60 %–70 % of new infections occur outside of monitored contacts.
- No approved vaccine for Bundibugyo; WHO has recommended initiating full-scale human trials of Ervebo, which has shown safety and efficacy against the Zaire strain and may offer partial protection against Bundibugyo.
Official Statements & Responses
- Mohamed Janabi, WHO’s regional director for Africa, told a news conference that early cases were misdiagnosed as malaria and typhoid, delaying the response. He emphasized the speed of the spread: “So we are chasing the virus, the virus is ahead of us.” “So we are chasing the virus, the virus is ahead of us,” — Mohamed Janabi, the WHO’s regional director for Africa
- Tedros Adhanom Ghebreyesus, WHO Director-General, warned that the outbreak is outpacing control efforts, noting that new cases are doubling in some hotspots and that a large share of infections are occurring beyond known contacts.
- WHO has urged the start of full-scale human trials for the Ervebo vaccine, citing early data that suggest possible cross-protection against Bundibugyo.
On-the-Ground Challenges
Health teams operate on remote, unpaved roads amid shortages of protective gear. Unpaid health workers have staged strikes over pay, and rebel groups have threatened responders, complicating access to affected communities. Misinformation campaigns claim Ebola “isn’t real,” fueling community anger and causing some pregnant women and others to avoid health centers. Displaced populations struggle to obtain clean water for hand hygiene, further hampering containment.
What’s Next
WHO’s recommendation to commence human trials of Ervebo marks the first major step toward a vaccine response for the Bundibugyo strain. Continued monitoring of case growth and expansion of protective equipment supplies are slated as immediate priorities, while negotiations with health-worker unions aim to resolve the strike and restore full staffing levels.
